Edap Tms (NASDAQ:EDAP) Now Covered by StockNews.com

StockNews.com started coverage on shares of Edap Tms (NASDAQ:EDAP) in a report published on Friday morning. The firm issued a hold rating on the medical equipment provider’s stock.

Edap Tms Stock Performance

NASDAQ:EDAP opened at $2.44 on Friday. The company has a current ratio of 2.18, a quick ratio of 1.46 and a debt-to-equity ratio of 0.08. Edap Tms has a 1 year low of $2.00 and a 1 year high of $8.50. The firm has a 50 day moving average of $2.27 and a 200-day moving average of $3.00.

Edap Tms (NASDAQ:EDAP) last issued its quarterly earnings data on Thursday, November 7th. The medical equipment provider reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.16) by ($0.03). Edap Tms had a negative net margin of 34.92% and a negative return on equity of 44.21%. The business had revenue of $14.42 million during the quarter, compared to the consensus estimate of $17.00 million. During the same quarter in the previous year, the firm posted ($0.12) EPS. Equities research analysts expect that Edap Tms will post -0.6 earnings per share for the current fiscal year.

Institutional Trading of Edap Tms

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Redhawk Wealth Advisors Inc. acquired a new stake in Edap Tms in the third quarter worth about $36,000. BNP Paribas Financial Markets boosted its stake in shares of Edap Tms by 23.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after purchasing an additional 4,400 shares during the last quarter. Parkman Healthcare Partners LLC acquired a new stake in shares of Edap Tms during the 3rd quarter worth approximately $395,000. Finally, Orion Capital Management LLC raised its stake in shares of Edap Tms by 10.4% during the third quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after buying an additional 6,600 shares during the last quarter. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology.